Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Etrolizumab vs placebo

Failure to respond at endpoint (6‐12 weeks) · patients with induction of remission in ulcerative colitis

Etrolizumab showed no clear difference in failure to respond at week 10 compared with placebo (moderate certainty).

1 finding from 1 review